-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Dual antiplatelet therapy is a standard care program for thrombosis prevention in patients undergoing percutaneous coronary intervention (PCI) .
Thrombosis prevention
Recently, researchers compared the safety and effectiveness of standard antiplatelet therapy versus selective guidance programs in PCI patients.
Recently, researchers compared the safety and effectiveness of standard antiplatelet therapy versus selective guidance programs in PCI patients.
This study is a systematic review and meta-analysis.
medsci.
.
Studies believe that compared with the standard clopidogrel prevention program, the selection of antiplatelet therapy based on the characteristics of hepatocyte cytochrome p4502c19 gene after PCI can improve the efficacy, improve safety, and reduce the risk of small bleeding.
Compared with the standard clopidogrel prevention program, selection of antiplatelet therapy based on the characteristics of hepatic cytochrome p4502c19 gene after PCI can improve the efficacy, improve safety, and reduce the risk of minor bleeding.
Original source:
Mattia Galli et al.
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Leave a message here